Medpace Holdings, Inc. (FRA:01P)

Market Cap	13.42B +73.1%
Revenue (ttm)	2.32B +24.2%
Net Income	399.30M +10.6%
EPS	13.79 +21.5%
Shares Out	n/a
PE Ratio	33.61
Forward PE	30.55
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	458.10
Previous Close	466.10
Day's Range	458.10 - 470.00
52-Week Range	263.60 - 558.20
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 22, 2026

About Medpace Holdings

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data man...

• Industry: Commercial Physical and Biological Research
• Founded: 1992
• Employees: 6,300
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 01P

Financial Performance

In 2025, Medpace Holdings's revenue was $2.53 billion, an increase of 19.97% compared to the previous year's $2.11 billion. Earnings were $451.12 million, an increase of 11.57%.

Financial numbers in USD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 18, 2026

Data Sources Report a data error